Goldan Keith A. sold SNDX
February 6, 2026 · Form 4 insider transaction
Goldan Keith A. sold 2,082 shares of Syndax Pharmaceuticals, Inc. at $20.62 per share, a transaction worth $42.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,082
Price
$20.62
Total value
$42.9K
InsiderGoldan Keith A.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 6, 2026
Filing dateFebruary 6, 2026
Shares owned after143,839
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.